德爾股份(300473.SZ):正籌劃發行股份等方式購買資產暨關聯交易事項 11月7日起停牌
格隆匯11月6日丨德爾股份(300473.SZ)公佈,公司正在籌劃發行股份等方式購買資產暨關聯交易事項(以下簡稱“本次交易”),因有關事項尚存不確定性,為了維護投資者利益,避免對公司證券交易造成重大影響,根據深圳證券交易所的相關規定,經公司申請,公司(證券品種:A股股票,證券簡稱:德爾股份,證券代碼:300473)自2024年11月7日開市時起開始停牌。
本次交易標的公司為愛卓智能科技(上海)有限公司(簡稱“愛卓科技”)。公司擬以發行股份等方式購買標的公司控制權,並募集配套資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.